Impact of patient ethnicity on the metabolic and immunologic effects of PI3K-mTOR pathway inhibition in patients with solid tumor malignancies. [electronic resource]
Producer: 20141028Description: 359-65 p. digitalISSN:- 1432-0843
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Biomarkers, Tumor -- metabolism
- Blood Glucose -- analysis
- Female
- Follow-Up Studies
- Glycated Hemoglobin -- metabolism
- Humans
- Insulin -- metabolism
- Male
- Middle Aged
- Neoplasms -- drug therapy
- Phosphoinositide-3 Kinase Inhibitors
- Prognosis
- Protein Kinase Inhibitors -- therapeutic use
- Proto-Oncogene Proteins c-akt -- antagonists & inhibitors
- Retrospective Studies
- Signal Transduction -- drug effects
- TOR Serine-Threonine Kinases -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.